Zdrowie i gospodarka · 03/06/2015
FDA Extends Comment Period for Draft Memorandum of Understanding on Compounded Human Drug Products
The Food and Drug Administration (FDA) is extending the comment period for a draft memorandum of understanding (MOU) on compounded human drug products, allowing interested persons more time to submit comments on the proposal.
Source: Federal Register — Food and Drug AdministrationOpen original release →